Posted by SLS on January 24, 2012, at 16:10:10
In reply to Re: Diabetes risk with Geodon? » sheilac, posted by tensor on January 24, 2012, at 14:44:31
It appears that Geodon (ziprasidone) is the AAP least likely to produce diabetes or other metabolic syndrome effects. People demonstrating metabolic effects with other AAPs are sometimes switched to Geodon.
- ScottSome see things as they are and ask why.
I dream of things that never were and ask why not.- George Bernard Shaw
poster:SLS
thread:1008283
URL: http://www.dr-bob.org/babble/20120120/msgs/1008290.html